FOI – 2023-000101 - Flumazenil Purchases (HTML)

Date received – 15 March 2023 | Date responded – 6 April 2023

Request

I understand that NHS bought much more midazolam than in previous years, during the recent covid situation.

Did they also increase their purchase of flumazenil?

Response

I can advise you that we have now completed the search of our records and can provide you with the following information:

The NHS in Scotland purchased a higher volume of flumazenil during 2020 before returning to pre-2020 levels in 2021. Data for 2022 indicates that purchases increased again but not to 2020 levels.

Please see below table detailing purchases of flumazenil by health boards via the national contract:

FLUMAZENIL 500MCG/5ML AMPOULES

• YEAR - 2019. AMPOULES PURCHASED = 5525
• YEAR - 2020. AMPOULES PURCHASED = 12900
• YEAR - 2021. AMPOULES PURCHASED = 5050
• YEAR - 2022. AMPOULES PURCHASED = 9310
• GRAND TOTAL = 32785

I trust you will find the information of assistance and if you require any further information, please do not hesitate to contact us.

If you are unhappy with any aspect of how we have dealt with your request, you can make representations to us asking us to review the handling of your request.

If you require any further information, please contact Head of Information and Cyber Security, Digital and Security within 40 working days of the date of this correspondence.

Contact

Address

If after a review you are still unhappy, you also have the right to apply to the Scottish Information Commissioner, who can be contacted at Kinburn Castle, St Andrews, Fife, KY16 9DS, or via their application form.

National Services Scotland (NSS) is committed to publishing all information released in response to Freedom of Information requests. You can view all FOI responses within our FOI Publications repository.